Doxil vs. Xeloda: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Doxil and Xeloda. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 242,970 people who take Doxil and Xeloda, and is updated regularly.
What is Doxil?
Doxil has active ingredients of doxorubicin hydrochloride. It is often used in ovarian cancer. eHealthMe is studying from 10,479 Doxil users. Check the latest studies of Doxil.
What is Xeloda?
Xeloda has active ingredients of capecitabine. It is often used in colon cancer. eHealthMe is studying from 46,649 Xeloda users. Check the latest studies of Xeloda.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
242,970 people who take Doxil and Xeloda are studied.
Drugs being compared in this study:
- Xeloda (capecitabine)
- Doxil (doxorubicin hydrochloride)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Doxil:
- not at all: 2.27 %
- somewhat: 18.18 %
- moderate: 22.73 %
- high: 34.09 %
- very high: 22.73 %
Xeloda:
- not at all: 4.85 %
- somewhat: 16.36 %
- moderate: 32.73 %
- high: 28.48 %
- very high: 17.58 %
Want to compare Doxil with Xeloda?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Pinto HP, Bhat RM, Shet D, Dandekeri S, "Compound mucocutaneous adverse effects of oral capecitabine in a patient", Indian dermatology online journal, 2014 Jan .
- Kang SM, Baek JY, Hwangbo B, Kim HY, Lee GK, Lee HS, "A case of capecitabine-induced sarcoidosis", Tuberculosis and respiratory diseases, 2012 Mar .
- Pinto HP, Bhat RM, Shet D, Dandekeri S, "Compound mucocutaneous adverse effects of oral capecitabine in a patient", Indian dermatology online journal, 2014 Jan .
- Kang SM, Baek JY, Hwangbo B, Kim HY, Lee GK, Lee HS, "A case of capecitabine-induced sarcoidosis", Tuberculosis and respiratory diseases, 2012 Mar .
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Doxil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Xeloda:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on doxorubicin hydrochloride and capecitabine (the active ingredients of Doxil and Xeloda, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Prilosec and Rubraca - now
- Drug interactions of Orencia and Ambien - 6 seconds ago
- Drug interactions of Capecitabine and Gliclazide - 17 seconds ago
- Pancreatitis Acute and Weakness - 20 seconds ago
- Drug interactions of Atracurium Besylate and Alprazolam - 20 seconds ago
- Profen and Limb Discomfort for Men aged 40-49 - 34 seconds ago
- Generalized Anxiety Disorder in Vyvanse, how severe and when it was recovered? - 41 seconds ago
- Omeprazole and Blood Creatine Phosphokinase Increased for Women aged 40-49 - 46 seconds ago
- Could Vitamin D3 cause Platelet Count Abnormal? - 47 seconds ago
- Nephrogenic Anaemia and Rhabdomyolysis - 57 seconds ago